The Feinstein IBD Center at Mount Sinai Hospital and the University of North Carolina worked together to create the Surveillance Epidemiology of Coronavirus Under Research Exclusion-IBD to track patients with inflammatory bowel disease who have COVID-19, the illness caused by the novel coronavirus. The project will examine the effect of IBD medications on the disease and whether patients with IBD are more susceptible to being infected with the virus.
Hospital, university tracking IBD patients with COVID-19
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.